Enhanced Wound Healing with Immune-Compatible iPSC-Derived Cells

Skip to main content
< All Topics
Print

Enhanced Wound Healing with Immune-Compatible iPSC-Derived Cells

This study describes how autologous induced pluripotent stem cell (iPSC) derivatives can promote wound healing without triggering an immune response. The work uses a non-human primate model to demonstrate the regenerative potential of patient-specific stem cell sources.

The findings support the development of personalized, immune-compatible regenerative therapies for wound care and skin repair.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.

Table of Contents